bendamustine hydrochloride has been researched along with daunorubicin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anger, G; Herold, M; Höche, D; Kästner, R | 1 |
| Guo, W; Huang, J; Huang, S; Huang, X; Jin, J; Li, F; Li, X; Ling, Q; Pan, J; Ye, W | 1 |
1 trial(s) available for bendamustine hydrochloride and daunorubicin
| Article | Year |
|---|---|
[Preliminary results of cyclically alternating chemotherapy (CVPP/DBVCy) in advanced Hodgkin's disease].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Bleomycin; Clinical Trials as Topic; Daunorubicin; Drug Administration Schedule; Female; Hodgkin Disease; Humans; Lomustine; Male; Middle Aged; Nitrogen Mustard Compounds; Prednisone; Procarbazine; Random Allocation; Vinblastine; Vincristine | 1987 |
1 other study(ies) available for bendamustine hydrochloride and daunorubicin
| Article | Year |
|---|---|
Novel SAHA‑bendamustine hybrid NL‑101 in combination with daunorubicin synergistically suppresses acute myeloid leukemia.
Topics: Animals; Bendamustine Hydrochloride; Cell Line, Tumor; Cell Proliferation; Cell Survival; Daunorubicin; DNA Damage; Drug Synergism; Female; HL-60 Cells; Humans; Leukemia, Myeloid, Acute; Mice; Vorinostat; Xenograft Model Antitumor Assays | 2020 |